Pharma stocks in heavy demand; zoom up to 20 pc

Image
Press Trust of India New Delhi
Last Updated : Apr 07 2020 | 7:54 PM IST

Pharma stockson Tuesday gained up to 20 per cent after the government relaxed export curbs on some pharma ingredients and medicines.

Shares of Morepen Laboratories zoomed 19.94 per cent, Nectar Lifesciences 19.93 per cent, Marksans Pharma 19.91 per cent, Vivimed Labs 19.38 per cent and RPG Life Sciences 18 per cent on the BSE.

Likewise, Aurobindo Pharma jumped 16.52 per cent, Laurus Labs gained 15.24 per cent, Indoco Remedies 13.94 per cent, Dr. Reddy's Laboratories 13.94 per cent and Torrent Pharmaceuticals 13.68 per cent.

AstraZeneca Pharma India stock jumped 12.08 per cent, Sun Pharmaceutical Industries 10.96 per cent, IPCA Laboratories 10.06 per cen, Jubilant Life Sciences 10 per cent and Natco Pharma 9.59 per cent.

The BSE Healthcare index jumped 8.95 per cent to close at 13,504.01.

"The government eased curbs on exports of 24 active pharmaceutical ingredients (APIs) and their formulations, which lifted the pharma index," Siddhartha Khemka, Head - Retail Research, Motilal Oswal Financial Services Ltd said.

The government on Monday relaxed export curbs on 24 pharma ingredients and medicines, including vitamin B1 and B12, according to an official notification.

The move assumes significance as certain pharma companies have raised concerns over these restrictions.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 07 2020 | 7:54 PM IST

Next Story